UBS analyst Gavin Parsons raised the firm’s price target on Northrop Grumman (NOC) to $643 from $614 and keeps a Buy rating on the shares. Northrop Grumman’s Q3 EPS and EBIT beat and raise were relatively uneventful, with revenue slightly below consensus, but with guidance reiterated, and initial 2025 revenue growth in-line at 3%-4%, the analyst tells investors in a research note. The past three quarters have seen steady operational performance and beats and raises in many areas of the business, the firm notes. Northrop Grumman is demonstrating a return to high quality growth, margin expansion and free cash flow generation, while executing on two of the DoD’s highest multi-decade priority programs, UBS argues.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NOC:
- Northrop Grumman says company backlog ‘large, well-diversified’
- Northrop Grumman says supply chain still has ‘broad-based challenges’
- Northrop Grumman expects strong cash generation in Q4
- Northrop Grumman sees International sales growing faster than rest of business
- Northrop Grumman provides 2024 segment guidance
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
